跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DUOPLAVIN 75 MG/100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
DUOPLAVIN 75 MG/100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Approved
STANDARD
DUOPLAVIN 75 MG/100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Sanofi-Aventis Groupe
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Feb 9, 2021
Approval ID
c22f919f7ca1e719
Company
Sanofi-Aventis Groupe
Type
Standard
Approval Details
Approval Id
c22f919f7ca1e719
Drug Cima Aemps Name
DUOPLAVIN 75 MG/100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA
Register Number
10619009IP
Holder Company Name
Sanofi-Aventis Groupe
Marketing Company Name
Melyfarma S.L.
Holder Company Detail Path
/organization/sanofi-aventis-groupe
Authorization Date
2021-02-09
Dosage Form
COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose
75 mg/100 mg
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
Yes
Company Name
Sanofi-Aventis Groupe
Company Detail Path
/organization/sanofi-aventis-groupe
Company Information
Pharmaceutical Company Name
SANOFI-AVENTIS GROUPE
Country Name
United Arab Emirates
City Name
dubai,dubai,country_ae
Address
5005, 5th Floor, Al Razi Building 64, Block C, Healthcare City
Active Ingredients
CLOPIDOGREL
75 mg
ACETILSALICILICO ACIDO
100 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Feb 9, 2021
Approval ID
c22f919f7ca1e719
Type
Standard
Back to CIMA-AEMPS Approvals